Biopolym. Cell. 1997; 13(6):503-508.
http://dx.doi.org/10.7124/bc.0004AE
Viruses and Cell
Studying of particular features of mixed infection of lymphocytes by HIV and some DNA-genomic lymphotropic viruses which may be associated with AIDS
1Dyachenko N. S., 2Rybalko S. L., 2Grytsak T. F., 2Maksimenok E. V., 2Djadiun S. T., 1Povnitsa O. Ju., 1Nesterova N. V., 1Beregovenko V. N., 3Pazkovsky Ju. V.
  1. D. K. Zabolotny Institute of Microbiology and Virology, NAS of Ukraine
    154, Academika Zabolotnogo Str., Kyiv, Ukraine, 03680
  2. Gromashevsky L.V. Institute of Epidemiology and Infection Diseases, AMS of Ukraine
    5, Amosova Str., Kyiv, Ukraine, 03038
  3. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680

Abstract

A model of mixed infection of lymphoblastic cells of T-phenotype was first designed using HIV and some DNA-genomic viruses which may be associated with AIDS (Epstein-Barr virus belonging to Herpesviridae and human adenovirus type 2). Considerable dec­reasing of HIV infection Hires as well as Ad hexon and EBV capsid proteins formation under triple (HIV+ Ad+ EBV) or double (HIV +Ad, HIV + EBV) infection of MT4 cells in different versions of non-simultaneous consecutive introduction of each virus were revealed, while HIV p24 expression levels were unchanged. Reverse transcriptase activity decreases upon triple infection of MT4/BIII cells chronically infected by HIV and producing it, while superinfection of cells by Ad increases level of enzyme. Drastic decreasing of interferone production was observed upon triple infection of lymphocytes from HIV-infected pacients and MT4 cells. Obtained data on mutual interference of HIV, Ad and EBV upon joint infection of cells are important for HIV-infection mechanism understanding, especially in conditions of latent lymphotropic viruses broad circulation among population of Ukraine in con­temporary ecological conditions.
Full text: (PDF, in Ukrainian)

References

[1] Carrigan DR, Knox KK, Tapper MA. Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6. J Infect Dis. 1990;162(4):844-51.
[2] Srinivasan A, Velpandi A, Monken CE, Plotkin SA, Ho W, Gonczol E, Ventura AM, Arens MR, Chinnadurai G. Activation and repression of HIV expression by heterologous viral genes. J Cell Biochem. 1990; Suppl. 14 D:95.
[3] Lusso P, Markham PD, DeRocco SE, Gallo RC. In vitro susceptibility of T lymphocytes from chimpanzees (Pan troglodytes) to human herpesvirus 6 (HHV-6): a potential animal model to study the interaction between HHV-6 and human immunodeficiency virus type 1 in vivo. J Virol. 1990;64(6):2751-8.
[4] Levy JA, Landay A, Lennette ET. Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture. J Clin Microbiol. 1990;28(10):2362-4.
[5] Enzensberger R, Braun W, July C, Helm EB, Doerr HW. Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection. Infection. 1991;19(3):140-5.
[6] Golden MP, Kim S, Hammer SM et al. Superinfection by HSY can after the pattern of HIV RNA expression. J Cell Biochem. 1991; Suppl. 15 E: 100
[7] Goldblum N, Daefler S, Liana T. Susceptibility to HIV-1 infection of a human B lymphoblastoid cell line DG-75, transfected with subgenomic DNA fragments of Epstein-Barr Virus. 21 congr. IABS progr. animal, retroviruses annecy: Proc symp. (4-6 Oct., 1989). Basel etc., 1990: 309.
[8] Tremblay M, Meloche S, Sekali RP, Wainberg MA. Complement-mediated antibody-dependent enhancement HIV- 1 infection in EBV-carrying B-cells. J Cell Biochem. 1990; Suppl. 14 D:128.
[9] Dahl KE, Burrage T, Jones F, Miller G. Persistent nonproductive infection of Epstein-Barr virus-transformed human B lymphocytes by human immunodeficiency virus type 1. J Virol. 1990;64(4):1771-83.
[10] Hierholzer JC, Wigand R, Anderson LJ, Adrian T, Gold JW. Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). J Infect Dis. 1988;158(4):804-13.
[11] Laspia M, Rice A, Mathewa M. Regulation of HIV-1 transcriptional of multiple levels: effects of HIV-1 tat and Adenovirus El A on transcriptional initiation and elongation. J Cell Biochem. 1990; Suppl. 14 D: 122.
[12] Berencsi G, Dyachenko NS, Tarassishin LA, Vantsak NP, Kovalishin GG, Kiseleva EK, Zhovnovataya VZ, Ad?m E, N?sz I. Changes of adenovirus hexon associated with different passage history of Ad h 1. Acta Microbiol Hung. 1986;33(3):233-43.
[13] Tarasishin LA. Immunoenzyme analysis and its modification in the study of viral antigens. Mikrobiol Zh. 1986;48(4):99-104.
[14] Voller A, Bartlett A, Bidwell DE, Clark MF, Adams AN. The detection of viruses by enzyme-linked immunosorbent assay (ELISA). J Gen Virol. 1976;33(1):165-7.
[15] Berger SL, Wallace DM, Puskas RS, Eschenfeldt WH. Reverse transcriptase and its associated ribonuclease H: interplay of two enzyme activities controls the yield of single-stranded complementary deoxyribonucleic acid. Biochemistry. 1983;22(10):2365-72.